
About Antibodies
Antibodies is a company based in Davis (United States) founded in 1960. The company has 23 employees. Antibodies offers products and services including Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies. Antibodies operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Davis, United States
- Employees 23
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website antibodiesinc.com
- Social LinkedIn X
- Legal Name Antibodies Inc.
- Latest Funding Round$497.41K (USD), Grant
Sep 2008
- Investors
- Employee Count23
Products & Services of Antibodies
Antibodies offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies.
Antibodies for detecting specific proteins in experiments
Kits for enzyme-linked immunosorbent assays in research
Tailored antibody production for scientific applications
Antibodies used in detection and amplification processes
Funding Insights of Antibodies
- Total Rounds 2
- Last Round Grant β $497,409
- First Round $746,063
(Sep 2008)
- Investors Count 1
All 2 funding rounds of Antibodies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Antibodies
Antibodies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Antibodies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Antibodies
4 people are tracked at Antibodies (1 in leadership, 3 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Will Fry | President | Leadership |
Jillian Strom | Research Associate II | Team |
Kristen Kralovich | Manager, Antibody Development | Team |
Catherine Fletter | Accounting Manager | Team |
Complete people profiles for Antibodies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Antibodies
3 dated milestones of Antibodies across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Antibodies is founded.
- Funding First funding round of $746K.
- Funding Latest funding round, Grant, of $497K.
Competitors of Antibodies
Antibodies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| abtis.co.kr | 2016 | Suwon-si, South Korea | $4.5M | – | Technology for antibody-drug conjugation is provided by AbTis. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| leinco.com | 1992 | St. Louis, United States | – | – | Manufacturer of antibodies, proteins, reagents, and kits for life science research | |
| icosagen.com | 2005 | Tartu, Estonia | – | – | Services in custom antibody and protein production are provided. |
Detailed competitors of Antibodies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Antibodies
The website of Antibodies (antibodiesinc.com) receives about 21K visits a month.
- Monthly visits21K
▼ 9% vs previous month
Websites whose visitors overlap most with Antibodies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sysy.com | 100% | 55.8K | #662,877 | View details | |
biotrend.com | biotrend.com | 94% | – | #4,074,352 | β |
affbiotech.com | affbiotech.com | 93% | – | #1,549,129 | β |
komabiotech.co.kr | komabiotech.co.kr | 93% | – | #1,931,229 | β |
| 3hbiomedical.com | 92% | 6.1K | #3,489,252 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Antibodies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Antibodies
Complete news archive for Antibodies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Antibodies
10 companies that operate in the same segment as Antibodies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Antibodies
Antibodies was founded in 1960 and raised its 1st funding round 48 years after it was founded.
Antibodies is headquartered in Davis, United States. It is registered at Davis, California, United States.
Antibodies has 23 employees.
Antibodies Incorporated was founded in 1960 in Davis, United States, within the biotechnology sector. Antibody-based IVD kits, primary and secondary antibodies, normal sera, immunochemicals, and labeling kits are produced using extensive animal facilities and advanced laboratories. Custom antibody development, scale-up processes, immuno-chemistry services, assay creation, and animal housing are provided to academic and research institutions.
Antibodies's top competitors include Sino Biological, GenScript and Y-Biologics.
Antibodies offers Primary Antibodies, ELISA Kits, Custom Antibody Development, and Secondary Antibodies.
Antibodies has 1 investor. Key investors include HHS.
Antibodies operates through Antibodies Inc..
